DE69430427T2 - Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade - Google Patents

Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade

Info

Publication number
DE69430427T2
DE69430427T2 DE69430427T DE69430427T DE69430427T2 DE 69430427 T2 DE69430427 T2 DE 69430427T2 DE 69430427 T DE69430427 T DE 69430427T DE 69430427 T DE69430427 T DE 69430427T DE 69430427 T2 DE69430427 T2 DE 69430427T2
Authority
DE
Germany
Prior art keywords
ropivacaine
use according
pharmaceutically acceptable
administered
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69430427T
Other languages
German (de)
English (en)
Other versions
DE69430427D1 (de
Inventor
Arne Torsten Eek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69430427(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of DE69430427D1 publication Critical patent/DE69430427D1/de
Publication of DE69430427T2 publication Critical patent/DE69430427T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Particle Accelerators (AREA)
  • Medicinal Preparation (AREA)
  • Air Conditioning Control Device (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Electromechanical Clocks (AREA)
  • Steroid Compounds (AREA)
DE69430427T 1993-06-28 1994-05-26 Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade Expired - Lifetime DE69430427T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use
PCT/SE1994/000496 WO1995000148A1 (en) 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade

Publications (2)

Publication Number Publication Date
DE69430427D1 DE69430427D1 (de) 2002-05-23
DE69430427T2 true DE69430427T2 (de) 2002-11-14

Family

ID=20390432

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69430427T Expired - Lifetime DE69430427T2 (de) 1993-06-28 1994-05-26 Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade
DE0706395T Pending DE706395T1 (de) 1993-06-28 1994-05-26 Verwendung von ropivacaine zur herstellung eines analgetikmus mit minimaler motorischer blockade

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE0706395T Pending DE706395T1 (de) 1993-06-28 1994-05-26 Verwendung von ropivacaine zur herstellung eines analgetikmus mit minimaler motorischer blockade

Country Status (32)

Country Link
US (2) US5670524A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0706395B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3725541B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1074918C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE216237T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9406865A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2165446C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ283300B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE69430427T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0706395T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EE (1) EE03205B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2099048T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI956269A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR970300013T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU218949B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL110006A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IS (1) IS4174A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LT (1) LT3449B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LV (1) LV12918B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY119360A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO955313L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ268110A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH31258A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL175518B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT706395E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2152215C1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SA (1) SA94150010B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE9302218D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG49078A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK280111B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW285640B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1995000148A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
AU742488B2 (en) * 1997-07-21 2002-01-03 Darwin Discovery Limited Levobupivacaine and its use
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
WO2009061497A1 (en) 2007-11-07 2009-05-14 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
JP2015516411A (ja) 2012-05-10 2015-06-11 ペインレフォーム リミテッド 疎水性有効成分のデポー製剤及びその調製方法
AU2013257727B2 (en) * 2012-05-10 2016-04-28 Cellixbio Private Limited Compositions and methods for the treatment of local pain
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
SG11201506789PA (en) 2013-02-28 2015-09-29 Dermira Inc Glycopyrrolate salts
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE40994T1 (de) * 1983-08-01 1989-03-15 Astra Laekemedel Ab L-n-n-propylpipekolsaeure-2,6-xylidid und dessen herstellung.
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
ATE216237T1 (de) 2002-05-15
SE9302218D0 (sv) 1993-06-28
NZ268110A (en) 1999-06-29
EE03205B1 (et) 1999-08-16
AU692161B2 (en) 1998-06-04
NO955313D0 (no) 1995-12-27
CZ283300B6 (cs) 1998-02-18
HU218949B (hu) 2001-01-29
FI956269A7 (fi) 1995-12-27
GR970300013T1 (en) 1997-05-31
JP3725541B2 (ja) 2005-12-14
SG49078A1 (en) 1998-05-18
JPH09500620A (ja) 1997-01-21
PH31258A (en) 1998-06-18
IL110006A (en) 1999-01-26
HU9503692D0 (en) 1996-02-28
CN1126435A (zh) 1996-07-10
WO1995000148A1 (en) 1995-01-05
SK280111B6 (sk) 1999-08-06
MY119360A (en) 2005-05-31
EP0706395B1 (en) 2002-04-17
FI956269L (fi) 1995-12-27
HK1010344A1 (en) 1999-06-17
SA94150010B1 (ar) 2006-04-04
US5670524A (en) 1997-09-23
CN1074918C (zh) 2001-11-21
US5834489A (en) 1998-11-10
DE69430427D1 (de) 2002-05-23
LV12918B (en) 2003-03-20
CA2165446A1 (en) 1995-01-05
HUT75115A (en) 1997-04-28
IL110006A0 (en) 1994-11-11
PL175518B1 (pl) 1999-01-29
FI956269A0 (fi) 1995-12-27
AU7086694A (en) 1995-01-17
TW285640B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1996-09-11
RU2152215C1 (ru) 2000-07-10
SK164695A3 (en) 1996-07-03
NO955313L (no) 1995-12-27
CZ336495A3 (en) 1996-06-12
DE706395T1 (de) 1997-09-04
ES2099048T1 (es) 1997-05-16
CA2165446C (en) 2005-07-05
LT3449B (en) 1995-10-25
LTIP1958A (en) 1995-01-31
ES2099048T3 (es) 2002-11-16
BR9406865A (pt) 1996-03-26
IS4174A (is) 1994-12-29
PL312198A1 (en) 1996-04-01
DK0706395T3 (da) 2002-07-22
PT706395E (pt) 2002-09-30
EP0706395A1 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
DE69805202T2 (de) Verwendung von benzhydrylsulfinylderivaten zur behandlung der schläfigkeit medikamentösen ursprungs
DE60008374T2 (de) Anästhetische zubereitung enthaltend einen nmda-antagonisten und einen alpha-2 adrenergen agonisten
DE3218761C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE69529156T2 (de) Verwendung von amino-hydrierten chinazolinverbindungen und ihren derivaten zur entwöhnung bei drogenabhängigkeit
DE10197266T5 (de) Verfahren zur örtlichen Betäubung und Schmerzstillung
DE69934305T2 (de) Verwendung von dexmedetomidine zur sedierung auf der intensivstation
ADAMS et al. The local anesthetic activity of tetrodotoxin alone and in combination with vasoconstrictors and local anesthetics
DE69430427T2 (de) Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade
DE69605531T2 (de) Carnitinderivat als Arzneimittel zur Behandlung von Arteriosklerose obliterans
DE69333413T2 (de) 5-ht2-antagonisten in der behandlung venöser zustände
DE3937340A1 (de) Verfahren zur erzeugung von analgesie bei saeugern
DE10039449A1 (de) Verwendung einer lokalanästhetikumhaltigen Zusammensetzung zur Behandlung von Hyperalgesien
DE69529819T2 (de) Neue kombination eines betablockers mit einem lokalanästhetikum
DE60206169T2 (de) Kombination enthaltend einen p-gp hemmer und einen antiepileptischen wirkstoff
DE69233432T2 (de) Verbesserte zusammensetzungen für die euthanasie
DE69304266T2 (de) Zusammensetzung enthaltend Dibucaine-Hydrochlorid, ein Salicylat, Calciumbromid und ein antiphlogistisches steroid zur Schmerzbekämpfung
DE69133419T2 (de) Verwendung von Adenosin und Adenosinderivaten für Analgesia
DE69118685T3 (de) Zusammensetzungen für euthanasie
DE69631597T2 (de) Kombination aus einem beta rezeptorblocker und einem opioid
AU692161C (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
DE10035865C2 (de) Verwendung von wässrigen Spraylösungen des lokalanästhetischen Mittels Lidocain zur prophylaktischen Behandlung von Migräne
Schmid et al. Regionale Opiatanalgesie
HK1010344B (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
Khan A Comparative Study of Intrathecal Dexmedetomidine and Buprenorphine as Adjuvant to Bupivacaine in Spinal Anaesthesia
AT517992A2 (de) Zusammensetzung enthaltend Methotrexat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8310 Action for declaration of annulment
8328 Change in the person/name/address of the agent

Representative=s name: HOFFMANN & EITLE, 81925 MUENCHEN

8330 Complete renunciation